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Background Starting with the 2010–2011 influenza season, the
Advisory Committee on Immunization Practices at the US
Centers for Disease Control and Prevention recommends annual
influenza vaccination to all people aged 6 months and older
unless contraindicated.
Objectives To measure perceived influenza vaccination
recommendation status among US adults (n = 2122) and its
association with socio-demographic characteristics and
recommendation status during the 2009–2010 pandemic influenza
season.
Methods We analyze nationally representative data from
longitudinal Internet surveys of US adults conducted in
November–December 2009 and September–October 2010.
Results During the 2010–2011 vaccination season, 46Æ2 percent
(95%-CI: 43Æ3–49Æ1%) of US adults correctly reported to be
covered by a government recommendation for influenza
vaccination. Awareness of being covered by a government
influenza vaccination recommendation was statistically
significantly higher among non-working adults and adults who
had been recommended for seasonal vaccination or both seasonal
and H1N1 vaccination during the 2009–2010 pandemic influenza
vaccination season.
Conclusion Our results highlight that a majority of US adults do
not know that they are recommended for annual influenza
vaccination by the government. The fraction of adults who are
unaware of their recommendation status is especially large among
newly recommended healthy young adults. The universal
vaccination recommendations will only be successful if they reach
both patients and physicians and lead to changing vaccination
practices. The universal nature of the new recommendation
simplifies vaccination-related outreach and compliance with
government vaccination guidelines considerably, as it does not
require any identification of specific recommendation groups
based on complex personal or health risk factors.
Keywords ACIP recommendations, influenza, influenza
vaccination, patient knowledge.
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Introduction
The Advisory Committee on Immunization Practices
(ACIP) at the US Centers for Disease Control and Preven-
tion (CDC)1 now recommends annual influenza vaccina-
tion for all people aged 6 months and older unless
contraindicated. The ACIP is the only entity in the US
federal government that formulates recommendations on
the use of vaccines by the US civilian population based on
careful review of the scientific evidence.2 Through endorse-
ments by medical professional societies and public health
authorities, ACIP recommendations influence the nature of
public health communication about vaccination and the
vaccine-related practices of healthcare provides. The new
ACIP recommendations of near universal annual influenza
vaccination were also publicized in the news media and on
the Internet, using some of the same communication tools
that had been deployed for informing the public during
the 2009 influenza A ⁄H1N1 pandemic (see, e.g., Flu.gov,
Accessed 9 August 2011).3
Prior to the 2010–2011 vaccination season, annual vaccina-
tion for influenza was based on a complex array of personal
characteristics such as age, occupation, living arrangements,
and existing health conditions that put individuals at elevated
risk of transmitting and contracting influenza or suffering
serious complications from a potential influenza infection.4
Pieced together, the risk-based recommendations covered
roughly 80% of the total US population.
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By extending recommendations to all healthy adults
aged 18–49 years, the ACIP influenza vaccination
recommendations became near universal. While the merits
of a near universal influenza vaccination recommendation
have long been debated, the recent pandemic brought
home the fact that novel strains of influenza can cause
severe illness in otherwise healthy, ‘‘low-risk’’ people.
Moreover, vaccinating healthy people also helps to protect
their close contacts who may be highly vulnerable to influ-
enza and its complications.
The new universal recommendation will also simplify
administrative procedures for influenza vaccination accord-
ing to ACIP guidelines by eliminating the step of verifying
patients’ recommendation status before discussing vaccina-
tion with patients in clinical practice. For example, previ-
ous research indicates that only one half of physician
practices were able to generate lists of patients with chronic
illnesses at high risk for complications of influenza. These
practices, in turn, were significantly more likely to use
patient reminders for influenza vaccination.5
While the universal vaccination recommendation simpli-
fies administrative procedures, it does not eliminate the
need to identify subgroups with low vaccination rates, who
are unaware of being recommended for annual influenza
vaccination and to target information about the benefits of
vaccination to these patient groups. To date, there is no
evidence regarding whether the US public is aware of the
new universal recommendation. Based on the experience of
last year’s pandemic, we suspect that healthy young adults
remain relatively unaware of being newly recommended for
annual influenza vaccination. During the pandemic, only
one-third of US adults who were recommended for either
or both seasonal or H1N1 influenza vaccination were aware
of it, highlighting gaps in public awareness about the risks
and benefits of influenza vaccination.6 To test this hypothe-
sis, we analyzed recently collected nationally representative
data on perceived recommendation status for influenza
vaccination among US adults and estimated its association
with socio-demographic characteristics and coverage by
ACIP’s previous, less comprehensive influenza vaccination
recommendations for the 2009–2010 pandemic vaccination
season. Comparing the perceived recommendation status of
newly and previously recommended persons, thereby,
allows us to assess whether the new universal recommenda-
tions have already resulted in levels of awareness among
newly recommended adults that are comparable with those
among persons who have already been recommended for
influenza vaccination during past vaccination seasons.
Methods
We employed survey data from two waves (9 and 12) of a
twelve-wave longitudinal survey effort to monitor US
adults’ knowledge, attitudes, beliefs, and behaviors with
regard to influenza and influenza prevention during the
2009–2010 influenza pandemic. The surveys were adminis-
tered to members of RAND’s American Life Panel (ALP), a
population-based Internet panel of US adults. The ALP
covers households with and without Internet access at the
time of recruitment by supplying WebTV or laptop com-
puters and high-speed Internet to participants who do not
have Internet access at the time of recruitment. A detailed
description of the panel as well as the questionnaires and
data used in this study is publicly available at https://
mmicdata.rand.org/alp/index.php/Main_Page.
The data for this analysis were collected between
November 19, 2009 and December 10, 2009 (wave 9) and
September 22, 2010 and October 25, 2010 (wave 12). Data
on our outcome of interest – adults’ knowledge of their
own influenza vaccination recommendation status – were
collected in wave 12 of the survey, which was completed
by 2628 ALP members (completion rate: 80Æ8 percent).
80Æ7 percent of wave 12 respondents had previously com-
pleted wave 9 of the survey, which gathered comprehensive
information about respondents’ influenza risk characteris-
tics corresponding to the criteria used by ACIP to define
its seasonal and H1N1 vaccination recommendations
during the 2009–2010 pandemic.4,7 Our final analytical
sample consisted of n = 2122 respondents who responded
to both survey waves (waves 9 and 12). Combining the two
survey waves did not only allow us to measure adults’
awareness of being currently covered by an influenza
vaccination recommendation, but also permitted us to
study the relationship between their current awareness of
their recommendation status for influenza vaccination
relative to their recommendation status during the 2009
influenza A ⁄H1N1 pandemic.
Awareness of being recommended for influenza during
the 2010–2011 vaccination season was measured by asking:
’’Each year, the federal government recommends which
members of the general population should get a flu vac-
cine. According to government recommendations, are you
recommended to get the flu vaccine this flu season (August
2010 to May 2011)? ’’ Permissible answers were ’’Yes,’’
’’No,’’ and ’’Don’t know’’ and we combined the categories
’’No,’’ and ’’Don’t know,’’ indicating lack of knowledge
about being covered by a government vaccination
recommendation for influenza.
We determined whether the respondents were recom-
mended for seasonal and ⁄or H1N1 vaccination during the
2009–2010 pandemic based on the risk factors measured in
November ⁄December 2009 (wave 9), the midpoint of the
pandemic. During this time, both seasonal and pandemic
vaccinations were recommended for healthcare workers,
pregnant women, adults aged 25–64 years with a high-risk
health condition, such as asthma, heart disease or diabetes,
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and adults with regular contact with children age 6 months
or younger. Seasonal vaccination was recommended for all
adults aged 50 years and older as well as for the persons in
regular contacts with adults aged 50 years and older or
children age 5 or younger. H1N1 vaccination was recom-
mended for all adults aged 18–24 years. Based on corre-
sponding measures available in survey wave 9, we
constructed detailed control variables for coverage by an
influenza vaccination recommendation during the past
pandemic season 2009–2010. Specifically, we constructed
age controls interacted with indicator variables for the pres-
ence of a high-risk health condition as well as additional
controls for regular contact with high-risk individuals,
which mirrored the ACIP recommendation criteria for sea-
sonal and pandemic vaccination of adults during the pan-
demic. In addition to detailed controls for adults’
recommendation status for influenza vaccination during
the 2009 influenza A ⁄H1N1 pandemic, the model also
included controls for respondents’ sex, race, educational
attainment, family income, and work status.
Statistical analyses were performed using STATA SE 10.1
software (StataCorp, College Station, TX, USA). Sample
characteristics and unadjusted associations were computed
using proportion estimation. Adjusted associations were
computed using a probit model that incorporated all of the
above controls simultaneously and were reported in terms
of average partial effects, i.e., the average percentage point
change in the probability of self-reported coverage by a
government vaccination recommendation for influenza
associated with a one-unit change in the value of a given
variable of interest, controlling for other characteristics. All
estimates were weighted to be nationally representative for
the US adult population using probability weights that
reflect the distribution of selected demographic characteris-
tics of the US adult population as obtained from the US
Current Population Survey (CPS). The RAND Corpora-
tion’s Institutional Reviewed Board approved the study
design and surveys.
Results
Overall, 46Æ2 percent of US adults correctly reported to be
covered by a government recommendation for influenza
vaccination during the 2010–2011 vaccination season
(Table 1). Table 1 also reports unweighted sample sizes
and weighted prevalence rates for all control variables
along with their unadjusted associations with respondents’
knowledge regarding their influenza vaccination recom-
mendation status. Knowledge of influenza vaccination
status varied significantly by race and ethnicity
(P = 0Æ026), with the highest level of knowledge among
non-Hispanic whites (49Æ1 percent). Likewise, knowledge
was considerably higher among non-working than among
working respondents (67Æ3 percent versus 37Æ8 percent,
P < 0Æ001) and among respondents who were recom-
mended for seasonal vaccination (56Æ4 percent) or for
both H1N1 and seasonal vaccination (54Æ8 percent) during
the 2009–2010 pandemic (P < 0Æ001). In addition, Table 1
shows considerable variation in self-reported coverage by
a 2010–2011 government influenza vaccination recommen-
dation across the different criteria of the targeted recom-
mendations during the 2009–2010 pandemic. Adults aged
65 years and older with and without a high-risk health
condition displayed the highest level of knowledge (88Æ3
percent and 84Æ4 percent), followed by adults aged 50–
64 years with a high-risk health condition (73Æ7 percent)
and healthcare workers (67Æ5 percent). Self-reported cover-
age by a government vaccination recommendation was
substantially lower among all other groups, rarely exceed-
ing 50 percent.
Table 2 reports adjusted associations obtained from mul-
tivariable probit models that simultaneously control for
socio-demographic characteristics and 2009–2010 recom-
mendation status. The latter is measured using the more
detailed set of controls for membership in a specific recom-
mendation group to capture the large, age-related variation
in self-reported coverage by a 2010–2011 government influ-
enza vaccination recommendation within the different
2009–2010 recommendations groups document in Table 1.
Accounting for 2009–2010 recommendation status, we
found no statistically significant associations between
knowledge of adults’ current recommendation status and
their socio-demographic characteristics with the exception
of work status. Everything else equal, working adults were
9Æ6 percentage points less likely to know about being
recommended for influenza vaccination than their non-
working counterparts.
In addition, the probit model showed that self-reported
coverage by a government vaccination recommendation for
the 2010–2011 vaccination season is closely related to age
and health status that defined previous recommendations
during the 2009–2010 pandemic and before. Persons aged
18–49 years with a high-risk health condition were 12Æ9
percentage points more likely to know about being recom-
mended for influenza vaccination than adults who were
not recommended for influenza vaccination in the past
(omitted category). Persons age 50–64 without and with a
high-risk health condition were 21 and 36Æ7 percentage
points more likely to know about their current recommen-
dation status than newly recommended persons who were
not by an age- or health-related government influenza vac-
cination recommendation in the past. Corresponding aver-
age partial effects for persons age 65 and older without and
with a high-risk health condition were 43Æ4 and 47Æ8 per-
centage points, respectively. Controlling for other factors,
young healthy adults aged 18–24 years, who were only
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recommended for H1N1 vaccination during the 2009–2010
vaccination season, displayed a 4Æ3 percentage point lower
levels of knowledge about being recommended for influ-
enza vaccination during the 2010–2011 influenza season
than healthy adults aged 25–49 years. Healthcare workers
were 23Æ5 percentage points more likely to know about
being recommended for influenza vaccination than newly
recommended persons, but the corresponding association
was considerably smaller and statistically insignificant for
household contacts of high-risk individuals. Moreover,
pregnant women or persons with regular contact with
infants aged 6 months or less showed no increased knowl-
edge about being recommended for influenza vaccination
compared with newly recommended healthy adults aged
25–49 years.
Discussion
Our study showed that at the start of the 2010–2011 influ-
enza vaccination season, less than half of US adults knew
that they were recommended for influenza vaccination by
the US government. This finding highlights the magnitude
of outreach required of public health officials and health-
care providers to increase adults’ awareness of their
Table 1. Socio-demographic and health characteristics and their bivariate association with self-reported coverage by a government influenza
vaccination recommendation, US adults, Fall 2010
Unweighted n
Weighted prevalence of
characteristic in % (95%-CI)
Self-reported coverage by government
vaccination recommendation
Weighted % (95%-CI)
Full sample 2122 100 46Æ2 (43Æ3;49Æ1)
Sex
Male 877 47Æ7 (44Æ8;50Æ6) 44Æ6 (40Æ3;49Æ0)
Female 1245 52Æ3 (49Æ4;55Æ2) 47Æ6 (43Æ8;51Æ4)
Race and ethnicity
Non-hispanic white 1841 74Æ2 (71Æ3;77Æ2) 49Æ1 (46Æ1;52Æ2)
Black 133 10Æ8 (8Æ7;12Æ9) 37Æ8 (28Æ0;47Æ7)
Hispanic 94 9Æ7 (7Æ5;11Æ9) 33Æ8 (22Æ3;45Æ2)
Other 54 5Æ3 (3Æ7;6Æ9) 44Æ6 (29Æ5;59Æ7)
Level of education
High school or lower 408 42Æ3 (39Æ2;45Æ4) 44Æ4 (38Æ9;49Æ9)
Some college 808 27Æ5 (25Æ3;29Æ7) 46Æ1 (41Æ9;50Æ2)
College degree 531 19Æ7 (17Æ7;21Æ6) 45Æ3 (40Æ2;50Æ3)
Masters degree or higher 375 10Æ5 (9Æ2;11Æ8) 55Æ4 (49Æ0;61Æ7)
Family income
Less than $50,000 913 49Æ9 (43Æ9;49Æ8) 47Æ6 (43Æ1;52Æ0)
$50,000 to $74,999 504 26Æ0 (23Æ4;28Æ6) 43Æ6 (38Æ0;49Æ3)
$75,000 or more 705 27Æ1 (24Æ8;29Æ5) 46Æ2 (41Æ6;50Æ9)
Currently working
No 598 28Æ4 (25Æ8;31Æ0) 67Æ3 (62Æ2;72Æ5)
Yes 1524 71Æ6 (69Æ0;74Æ2) 37Æ8 (34Æ6;41Æ0)
Overall recommendation status during the past influenza season
No vaccination recommendation 387 24Æ0 (21Æ4;26Æ7) 22Æ3 (17Æ1;27Æ6)
H1N1 vaccination only 49 4Æ0 (2Æ6;5Æ4) 18Æ1 (6Æ2;30Æ1)
Seasonal vaccination only 962 38Æ8 (36Æ1;41Æ5) 56Æ4 (52Æ3;60Æ6)
Both H1N1 and seasonal vaccination 724 33Æ2 (30Æ5;36Æ0) 54Æ8 (49Æ7;60Æ0)
Detailed characteristics defining 2009–2010 recommendation status
Age 18–24 years without high-risk condition 96 6Æ8 (5Æ1;8Æ4) 23Æ9 (14Æ2;33Æ5)
Age 50–64 years without high-risk condition 583 16Æ8 (15Æ1;18Æ6) 51Æ2 (45Æ9;56Æ5)
Age 65 + years without high-risk condition 186 8Æ1 (6Æ8;9Æ4) 84Æ4 (78Æ3;90Æ5)
Age 65 + years with high-risk condition 151 9Æ0 (7Æ2;10Æ7) 88Æ3 (82Æ2;94Æ4)
Household contact of high-risk person 844 38Æ2 (35Æ5;41Æ0) 52Æ0 (47Æ5;56Æ5)
Pregnant woman or contact of infant 95 4Æ8 (3Æ5;6Æ1) 40Æ2 (27Æ0;53Æ3)
Age 18–49 years with high-risk condition 178 11Æ8 (9Æ6;13Æ9) 41Æ4 (31Æ7;51Æ0)
Age 50–64 years with high-risk condition 245 7Æ5 (6Æ3;8Æ7) 73Æ7 (65Æ5;81Æ9)
Formal or informal healthcare worker 286 12Æ5 (10Æ7;14Æ4) 67Æ5 (59Æ9;75Æ1)
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recommendation status. Awareness of one’s recommenda-
tion status was especially low among young healthy adults
who were not recommended for any type of influenza vac-
cination or recommended for H1N1 vaccination only dur-
ing the 2009–2010 pandemic vaccination season. The latter
finding is especially noteworthy as the inclusion of the
2009 influenza A ⁄H1N1 strain in the 2010–2011 influenza
vaccine was aimed at protecting this highly vulnerable
population group in particular.7,8 The relatively low levels
of awareness among newly recommended adults compared
to adults who have already been recommended for sea-
sonal influenza vaccination in the past also reveal limited
awareness of last year’s changes in ACIP’s influenza vacci-
nation recommendations and highlight the need for addi-
tional communication efforts highlighting the universal
nature of the new vaccination recommendations for influ-
enza. Particularly, as awareness seems especially low
among working adults, employer-based outreach programs
such as employer-based reminder systems and company
flu shot clinics may be a promising tool for increasing
awareness and cost-effective vaccine use among newly tar-
geted young, healthy adults.9 Similarly, the comparatively
low rates of awareness among certain traditional recom-
mendation groups such as pregnant women and house-
hold contacts of infants call for increased efforts to
highlight the importance of influenza vaccination for preg-
nant women and caregivers of young children during rou-
tine care visits to obstetricians or pediatricians.
Our study has several limitations. First, despite adopting
a probability-based sample design that covers both online
Table 2. Multivariable probit model for self-reported coverage by a government influenza vaccination recommendation with socio-demographic
and health controls, US adults, Fall 2010
Average partial effect
Estimate in percentage points (95%-CI)
Sex
Male Reference category
Female 1Æ5 ()3Æ4;6Æ5)
Race and ethnicity
Non-hispanic white Reference category
Black )3Æ5 ()12Æ7;5Æ6)
Hispanic )5Æ4 ()16Æ2;5Æ4)
Other 0Æ5 ()12Æ7;13Æ7)
Level of education
High school or lower Reference category
Some college 2Æ4 ()3Æ6;8Æ4)
College degree 1Æ9 ()4Æ7;8Æ5)
Masters degree or higher 7Æ3 ()0Æ5;15Æ1)
Family income
Less than $50,000 Reference category
$50,000 to $74,999 )0Æ4 ()6Æ8;6Æ0)
$75,000 or more )0Æ1 ()6Æ1;6Æ0)
Currently working
No Reference category
Yes )9Æ6 ()16Æ7;)2Æ4)
Detailed recommendation status during the past influenza season
No vaccination recommendation Reference category
H1N1 vaccination only
Age 18–24 without high-risk condition )4Æ3 ()14Æ7;6Æ2)
Seasonal vaccination only
Age 50–64 without high-risk condition 21Æ0 (15Æ1;26Æ8)
Age 65 + without high-risk condition 43Æ4 (37Æ3;49Æ5)
Age 65 + with high-risk condition 47Æ8 (41Æ9;53Æ6)
Household contact of high-risk person 4Æ9 ()0Æ4;10Æ1)
Both H1N1 and seasonal vaccination
Pregnant woman or contact of infant 0Æ0 ()11Æ5;11Æ5)
Age 18–49 years with high-risk condition 12Æ9 (4Æ2;21Æ5)
Age 50–64 years with high-risk condition 36Æ7 (30Æ0;43Æ4)
Formal or informal healthcare worker 23Æ5 (15Æ7;31Æ2)
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and offline households, the decision to participate in the
ALP could be associated with awareness of one’s recom-
mendation status in a way that compromises the external
validity of our findings. Likewise, as many ALP members
participated in several influenza vaccination surveys during
the pandemic, ’’learning effects’’ or panel conditioning may
have affected our results. Particularly, our estimates of
knowledge of adults’ recommendation status are somewhat
larger compared with previous estimates of adults’ aware-
ness of their influenza vaccination recommendation status
during the pandemic6. This difference may reflect genuine
increases in the awareness of adults with regard to govern-
ment influenza vaccination recommendations or confusion
during the pandemic with regard to the distinct recom-
mendations for seasonal and pandemic vaccination, respec-
tively, but may also reflect differences in sample source,
survey methodology, or potential learning effects. In gen-
eral, our estimates appear conservative, as both potential
biases mentioned earlier suggest that adults’ awareness of
their government recommendation status for influenza
vaccination is, if anything, estimated too high.
The new universal vaccination recommendation for
influenza should facilitate the streamlining of public
health communication and the initiation of counseling by
healthcare providers about the benefits of annual influenza
vaccination. This is because compliance with official rec-
ommendations no longer requires time-consuming admin-
istrative procedures aimed at identifying subgroups of
recommended patients based on their age, health, or con-
tact with high-risk individuals, many of which are not
routinely documented in medical record and other admin-
istrative data. In this way, messaging can more efficiently
address the attitudinal and access barriers to vaccination
irrespective of demographic and clinical characteristics.
Eliminating the administrative complexity associated with
targeting recommended subgroups based on demographic
and clinical characteristics should facilitate the implemen-
tation of evidence-based, but underused strategies for
communicating the benefits of vaccination, including one-
on-one counseling by healthcare providers during office
visits, the use of phone, email, or postcard patient remind-
ers of physicians and employers or the increased use of
social media.10–19 However, the universal vaccination rec-
ommendations will only be successful if they reach both
patients and physicians and lead to changing vaccination
practices. It has never been easier.
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